You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Boehringer Ingelheim
Moodys
Medtronic
Merck

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

DIETHYLPROPION HYDROCHLORIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Diethylpropion Hydrochloride patents expire, and what generic alternatives are available?

Diethylpropion Hydrochloride is a drug marketed by Lannett Co Inc, Avanthi Inc, Chartwell Rx, Epic Pharma Llc, Sandoz, Teva, Ucb Inc, and Watson Labs. and is included in ten NDAs.

The generic ingredient in DIETHYLPROPION HYDROCHLORIDE is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Diethylpropion Hydrochloride

A generic version of DIETHYLPROPION HYDROCHLORIDE was approved as diethylpropion hydrochloride by AVANTHI INC on December 22nd, 2010.

  Start Trial

Drug patent expirations by year for DIETHYLPROPION HYDROCHLORIDE
Recent Clinical Trials for DIETHYLPROPION HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GlaxoSmithKlineN/A
New River PharmaceuticalsPhase 1/Phase 2

See all DIETHYLPROPION HYDROCHLORIDE clinical trials

Pharmacology for DIETHYLPROPION HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DIETHYLPROPION HYDROCHLORIDE

US Patents and Regulatory Information for DIETHYLPROPION HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Co Inc DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 091680-001 Oct 24, 2011 AB RX No Yes   Start Trial   Start Trial   Start Trial
Sandoz DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 085916-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Chartwell Rx DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 088268-001 Aug 25, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Mallinckrodt
McKesson
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.